Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
Summary Bacterial vectors, as microscopic living ‘robotic factories’, can be reprogrammed into microscopic living ‘robotic factories’, using a top‐down bioengineering approach to produce and deliver anticancer agents. Most of the current research has focused on bacterial species such as Salmonella t...
Main Authors: | Xiaoli Yu, Changsen Lin, Jing Yu, Qingsheng Qi, Qian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-05-01
|
Series: | Microbial Biotechnology |
Online Access: | https://doi.org/10.1111/1751-7915.13523 |
Similar Items
-
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda ALTUNTAŞ, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Bioengineering of <i>Escherichia coli Nissle 1917</i> for Production and Excretion of Spermidine, a Key Metabolite in Human Health
by: Clément Caffaratti, et al.
Published: (2022-11-01)